Skip to main content

Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects

  • Conference paper
Acute Leukemias II

Abstract

The enzyme terminal deoxynucleotidyl transferase (TdT) is expressed on the nuclear membrane of normal precursor B and T cells as well as their malignant counterparts, i.e., acute lymphoblastic leukemias (ALLs) and some lymphoblastic lymphomas [1, 2]. TdT expression has also been found in 5%–46% of acute nonlymphocytic leukemias (ANLLs) [3–9]. In ANLL there is a large variability in the percentage of TdT+ cells, and also the intensity of TdT expression varies per cell. In most studies a limit of at least 10% of TdT+ cells was adopted for the diagnosis of a TdT+ ANLL. However, it is likely that in some ANLLs smaller TdT+ leukemic subpopulations are present.

This work was supported by the Sophia Foundation for Medical Research

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bollum FJ (1979) Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54:1203–1215

    PubMed  CAS  Google Scholar 

  2. Janossy G, Hoffbrand AV, Greaves MF, Ganeshaguru K, Pain C, Bradstock KF, Prentice HG, Kay HEM, Lister TA (1980) Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia:a multiparameter analysis of 300 cases. Br J Haematol 44:221–234

    Article  PubMed  CAS  Google Scholar 

  3. Bradstock KF, Hoffbrand AV, Ganeshaguru K, Llewellin P, Patterson K, Wonke B, Prentice AG, Bennett M, Pizzolo G, Bollum FJ, Janossy G (1981) Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukaemia:an analysis by immunofluorescence. Br J Haematol 47:133–143

    Article  PubMed  CAS  Google Scholar 

  4. Jani P, Verbi W, Greaves MF, Bevan D, Bollum F (1983) Terminal deoxynucleotidyl transferase in acute myeloid leukaemia. Leuk Res 7:17–29

    Article  PubMed  CAS  Google Scholar 

  5. Lanham GR, Melvin SL, Stass SA (1985) Immunoperoxidase determination of terminal deoxynucleotidyl transferase in acute leukemia using PAP and ABC methods:experience in 102 cases. Am J Clin Pathol 83:366–370

    PubMed  CAS  Google Scholar 

  6. Krause JR, Brody JP, Kaplan SS, Penchansky L (1986) Terminal deoxynucleotidyl transferase activity in acute leukemia:a study of 100 cases comparing an immunoperoxidase (PAP) vs. immunofluorescent method. Am J Hematol 22:179–184

    Article  PubMed  CAS  Google Scholar 

  7. Kaplan SS, Penchansky L, Krause JR, Basford RE, Zdziarski U (1987) Simultaneous evaluation of terminal deoxynucleotidyl transferase and myeloperoxidase in acute leukemias using an immunocytochemical method. Am J Clin Pathol 87:732–738

    PubMed  CAS  Google Scholar 

  8. Erber WN, Mason DY (1987) Immunoalka- line phosphatase labeling of terminal transferase in hematologic samples. Am J Clin Pathol 88:43–50

    PubMed  CAS  Google Scholar 

  9. Parreira A, Pombo de Oliveira MS, Matutes E, Foroni L, Morilla R, Catovsky D (1988) Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia:an association with immature myeloblasts leukaemia. Br J Haematol 69:219–224

    Article  PubMed  CAS  Google Scholar 

  10. Van Dongen JJM, Adriaansen HJ, Hooijkaas H (1987) Immunological marker analysis of cells in the various hematopoietic differentiation stages and their malignant counterparts. In:Ruiter DJ, Fleuren GJ, Warnaar SO (eds) Application of monoclonal antibodies in tumor pathology. Nijhoff, Dordrecht, pp 87–116

    Chapter  Google Scholar 

  11. Adriaansen HJ, Van Dongen JJM, Kappers- Klunne MC, Hählen K, Van’t Veer MB, Wijdenes-de Bresser JHFM, Holdrinet ACJM, Harthoorn-Lasthuizen EJ, Abels J, Hooijkaas H (submitted) Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL. Implications for the detection of minimal disease

    Google Scholar 

  12. Janossy G, Bollum FJ, Bradstock KF, McMichael A, Rapson N, Greaves MF (1979) Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol 123:1525–1529

    PubMed  CAS  Google Scholar 

  13. Bradstock KF, Kerr A, Kabral A, Favaloro EJ, Hewson JW (1986) Coexpression of pi 65 myeloid surface antigen and terminal de-oxynucleotidyl transferase:a comparison of acute myeloid leukaemia and normal bone marrow cells. Am J Hematol 23:43–50

    Article  PubMed  CAS  Google Scholar 

  14. Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316:1111–1117

    Article  PubMed  CAS  Google Scholar 

  15. Desiderio SV, Yancopoulos GD, Paskind M, Thomas E, Boss MA, Landau N, Alt FW, Baltimore D (1984) Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311:752–755

    Article  PubMed  CAS  Google Scholar 

  16. Landau NR, Schatz DG, Rosa M, Baltimore D (1987) Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol Cell Biol 7:3237–3243

    PubMed  CAS  Google Scholar 

  17. Van Dongen JJM, Hooijkaas H, Adriaansen HJ, Hählen K, Van Zanen GE (1986) Detection of minimal residual acute lymphoblastic leukemia by immunological marker analysis:possibilities and limitations. In:Hagenbeek A, Lowenberg B (eds) Minimal residual disease in acute leukemia 1986. Nijhoff, Dordrecht, pp 113–133

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Adriaansen, H.J., Hooijkaas, H., Kappers-Klunne, M.C., Hählen, K., van’t Veer, M.B., van Dongen, J.J.M. (1990). Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74643-7_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50984-4

  • Online ISBN: 978-3-642-74643-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics